ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition
Top Cited Papers
- 1 January 2004
- Vol. 41 (2) , 193-202
- https://doi.org/10.1016/s0896-6273(03)00850-x
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- In VivoAssessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-LifeJournal of Neuroscience, 2003
- Apolipoprotein J (clusterin) and Alzheimer's diseaseMicroscopy Research and Technique, 2000
- Apolipoprotein E is essential for amyloid deposition in theAPPV717Ftransgenic mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 1999
- Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal culturesMolecular Brain Research, 1999
- Lack of apolipoprotein E dramatically reduces amyloid β-peptide depositionNature Genetics, 1997
- Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor ProteinsNeuron, 1997
- Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) NeurotoxicityJournal of Neurochemistry, 1996
- Co-expression of β-amyloid precursor protein (βAPP) and apolipoprotein E in cell culture: analysis of βAPP processingNeurobiology of Disease, 1995
- Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein EBiochemical Journal, 1995
- Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.Journal of Clinical Investigation, 1985